In a small study of 16 patients with the rare cancer angiosarcoma, tumors in four patients partially or completely responded to treatment with a combination of the immunotherapy drugs ipilimumab and ...
A previous version of this article appeared on Targeted Oncology ™. Although immunotherapy has become a mainstay of treatment for various types of cancer, it has been less successful in treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback